Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients

S. E.M. Lucas; K. Raspin; J. Mackintosh; I. Glaspole; P. N. Reynolds; C. Chia; C. Grainge; P. Kendall; L. Troy; D. A. Schwartz; Richard Wood-Baker; S. L.F. Walsh; Y. Moodley; J. Robertson; S. Macansh; E. H. Walters; D. Chambers; T. J. Corte; J. L. Dickinson

doi:10.1016/j.pulmoe.2022.09.002

Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients

S. E.M. Lucas, K. Raspin, J. Mackintosh, I. Glaspole, P. N. Reynolds, C. Chia, C. Grainge, P. Kendall, L. Troy, D. A. Schwartz, Richard Wood-Baker, S. L.F. Walsh, Y. Moodley, J. Robertson, S. Macansh, E. H. Walters, D. Chambers, T. J. Corte, J. L. Dickinson

Internal Medicine

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	257-260
Number of pages	4
Journal	Pulmonology
Volume	29
Issue number	3
DOIs	https://doi.org/10.1016/j.pulmoe.2022.09.002
Publication status	Published - 1 May 2023

Access to Document

10.1016/j.pulmoe.2022.09.002Licence: CC BY-NC-ND

Cite this

Lucas, S. E. M., Raspin, K., Mackintosh, J., Glaspole, I., Reynolds, P. N., Chia, C., Grainge, C., Kendall, P., Troy, L., Schwartz, D. A., Wood-Baker, R., Walsh, S. L. F., Moodley, Y., Robertson, J., Macansh, S., Walters, E. H., Chambers, D., Corte, T. J., & Dickinson, J. L. (2023). Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology, 29(3), 257-260. https://doi.org/10.1016/j.pulmoe.2022.09.002

@article{731adc82308f4fd9a9eb0e6a18e74cfc,

title = "Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients",

author = "Lucas, {S. E.M.} and K. Raspin and J. Mackintosh and I. Glaspole and Reynolds, {P. N.} and C. Chia and C. Grainge and P. Kendall and L. Troy and Schwartz, {D. A.} and Richard Wood-Baker and Walsh, {S. L.F.} and Y. Moodley and J. Robertson and S. Macansh and Walters, {E. H.} and D. Chambers and Corte, {T. J.} and Dickinson, {J. L.}",

note = "Funding Information: We are greatly indebted to our participants and their families for volunteering their time and clinical data; without their participation, this study would not be possible. We also thank the ILD nurses and coordinators, including Catriona Doran from Royal Adelaide Hospital; Elizabeth Ray, Shannon Cleary, Jessica Rhodes and Qi Lin from Royal Prince Alfred Hospital; Amy Cashmore from John Hunter Hospital; Sandra Bancroft from The Prince Charles Hospital; Karen Symons from The Alfred; Shona Knights-Rennie from Border Physicians Group; Samantha Wadham and Helen Rodgers from Sunshine Coast University Hospital and; David Clark from PathWest Albany. The Australian IPF Registry is facilitated by Lung Foundation Australia and is supported by unrestricted educational grants from Foundation Partners, Boehringer Ingelheim and Roche Products, Pty. Limited. SEML, PR, LT, DAS, RWB, SW, YM, SM, HW, DC, TJC and JLD made substantial contributions to the conception and design of the study; SL, KR, SM, TJC, LT, IG, PNR, DC, CC, CG, JR and PK made substantial contributions to the acquisition of patients and clinical data; SEML and JM conducted data analysis; SEML; KR; JM and TLC and JLD made substantial contributions to the interpretation of the data; SEML and JLD drafted the manuscript; while all authors were involved in revising the manuscript critically for important intellectual content; gave final approval for publishing; and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. SEML, TJC and JLD are guarantors of this work, taking responsibility for the integrity of the work as a whole, from inception to published article.",

year = "2023",

month = may,

day = "1",

doi = "10.1016/j.pulmoe.2022.09.002",

language = "English",

volume = "29",

pages = "257--260",

journal = "Pulmonology",

issn = "2531-0429",

publisher = "Elsevier Espana",

number = "3",

}

Lucas, SEM, Raspin, K, Mackintosh, J, Glaspole, I, Reynolds, PN, Chia, C, Grainge, C, Kendall, P, Troy, L, Schwartz, DA, Wood-Baker, R, Walsh, SLF, Moodley, Y, Robertson, J, Macansh, S, Walters, EH, Chambers, D, Corte, TJ & Dickinson, JL 2023, 'Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients', Pulmonology, vol. 29, no. 3, pp. 257-260. https://doi.org/10.1016/j.pulmoe.2022.09.002

TY - JOUR

T1 - Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients

AU - Lucas, S. E.M.

AU - Raspin, K.

AU - Mackintosh, J.

AU - Glaspole, I.

AU - Reynolds, P. N.

AU - Chia, C.

AU - Grainge, C.

AU - Kendall, P.

AU - Troy, L.

AU - Schwartz, D. A.

AU - Wood-Baker, Richard

AU - Walsh, S. L.F.

AU - Moodley, Y.

AU - Robertson, J.

AU - Macansh, S.

AU - Walters, E. H.

AU - Chambers, D.

AU - Corte, T. J.

AU - Dickinson, J. L.

N1 - Funding Information: We are greatly indebted to our participants and their families for volunteering their time and clinical data; without their participation, this study would not be possible. We also thank the ILD nurses and coordinators, including Catriona Doran from Royal Adelaide Hospital; Elizabeth Ray, Shannon Cleary, Jessica Rhodes and Qi Lin from Royal Prince Alfred Hospital; Amy Cashmore from John Hunter Hospital; Sandra Bancroft from The Prince Charles Hospital; Karen Symons from The Alfred; Shona Knights-Rennie from Border Physicians Group; Samantha Wadham and Helen Rodgers from Sunshine Coast University Hospital and; David Clark from PathWest Albany. The Australian IPF Registry is facilitated by Lung Foundation Australia and is supported by unrestricted educational grants from Foundation Partners, Boehringer Ingelheim and Roche Products, Pty. Limited. SEML, PR, LT, DAS, RWB, SW, YM, SM, HW, DC, TJC and JLD made substantial contributions to the conception and design of the study; SL, KR, SM, TJC, LT, IG, PNR, DC, CC, CG, JR and PK made substantial contributions to the acquisition of patients and clinical data; SEML and JM conducted data analysis; SEML; KR; JM and TLC and JLD made substantial contributions to the interpretation of the data; SEML and JLD drafted the manuscript; while all authors were involved in revising the manuscript critically for important intellectual content; gave final approval for publishing; and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. SEML, TJC and JLD are guarantors of this work, taking responsibility for the integrity of the work as a whole, from inception to published article.

PY - 2023/5/1

Y1 - 2023/5/1

UR - http://www.scopus.com/inward/record.url?scp=85153483261&partnerID=8YFLogxK

U2 - 10.1016/j.pulmoe.2022.09.002

DO - 10.1016/j.pulmoe.2022.09.002

M3 - Letter

C2 - 36216738

AN - SCOPUS:85153483261

SN - 2531-0429

VL - 29

SP - 257

EP - 260

JO - Pulmonology

JF - Pulmonology

IS - 3

ER -

Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients

Access to Document

Other files and links

Cite this